Pascal Soriot

Type: Person
Name: Pascal Soriot
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

City Spy: Cobra’s success a case of tabling a resolution

Lord Bilimoria was in sparkling form at last night’s Evening Standard Business Connections event.The Cobra Beer founder recounted how a mixture of luck, determination and creativity is required by would-be entrepreneurs.In his case, good fortune smiled ... [Published London Evening Standard - Sep 11 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 2 reports

The Benefits Of Investing In AstraZeneca plc

Today I am outlining why AstraZeneca (LSE: AZN) (NYSE: AZN.US) could be considered an attractive addition to any stocks portfolio.Drugs pipeline perking upAstraZeneca has often been accused of lagging its industry rivals in terms of developing the next ... [Published Motley Fool UK - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

AstraZeneca's Soriot brushes off chatter about new Pfizer bid

AstraZeneca CEO Pascal SoriotWith rampant speculation that Pfizer ($PFE) might renew its effort to buy AstraZeneca ($AZN), one might assume the takeover target's CEO, Pascal Soriot, would be locked up in meetings, devising a strategy for fending off the ... [Published FiercePharma - Sep 03 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Exclusive: 'Back To Normal' For AstraZeneca CEO, Despite Pfizer Rumors

By Clip Syndicate Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona.recommend this article ... [Published IT Business Net - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors

By Ben HirschlerBARCELONA (Reuters) - Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona."The ... [Published Bayou Buzz - Sep 02 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

The Best Reason To Buy AstraZeneca plc

The FTSE's second-biggest pharmaceuticals company AstraZeneca (LSE:AZN) (NYSE: AZN) has been in the news over the past year, with its share price having been boosted by the Pfizer bid attempt, to 4,573p today.But are AstraZeneca shares worth buying? I ... [Published Interactive Investor - Aug 29 2014]
First reported Aug 27 2014 - Updated Aug 28 2014 - 1 reports

Heart disease to cost UK £18.4bn by 2020

In less than six years heart disease will cost the UK €23.1bn (£18.4bn), according to the Centre for Economic and Business Research.The UK will be one of the hardest hit countries in Western Europe by cardiovascular disease, the figures suggest, with ... [Published City A.M. - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 2 reports

Window opens for Pfizer move on AstraZeneca

Published:US drugs giant Pfizer can today renew its ambitions to buy AstraZeneca in a £69billion mega-deal.The Viagra-maker is looking for a way to slash its global tax bill by shifting its tax base out of the US. Its initial attempts to buy Astra, Britain’s ... [Published Mail Online UK - Aug 25 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

The Risks Of Investing In AstraZeneca plc

Today I am highlighting what you need to know before investing in AstraZeneca (LSE: AZN) (NYSE: AZN.US).Sales projections to haunt AstraZeneca later on?In a bid to stave off the overtures of US rival Pfizer, AstraZeneca chief executive Pascal Soriot announced ... [Published Yahoo! UK and Ireland - Aug 21 2014]
First reported Aug 19 2014 - Updated Aug 20 2014 - 7 reports

AstraZeneca says Justice probe is over

AstraZeneca's campus in Wilmington, Del. ( / Staff)Travel DealsPosted: Tuesday, August 19, 2014, 4:33 PMDrugmaker AstraZeneca said Tuesday the U.S. Justice Department notified the British-based company that it was no longer investigating allegations of ... [Published Philly.com - Aug 19 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 15 reports

U.S.ends probe of AstroZeneca's allegedly rigged clinical trial

The U.S. Department of Justice today announced they are concluding their investigation into a clinical trial for AstraZeneca's Brilinta (ticagrelor), a drug prescribed for patients with acute coronary syndrome. Federal officials first issued a request ... [Published CBS News - Aug 19 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 4 reports

AstraZeneca chief increases stake

Pascal Soriot buys 46,200 shares at £43.45 each on Monday, increasing by nearly a third his personal stake in Britain’s second-biggest drugmaker ... [Published FT.com - UK News - Jul 01 2014]

More Content

All (157) | News (129) | Reports (0) | Blogs (20) | Audio/Video (0) | Fact Sheets (0) | Press Releases (6)
sort by: Date | Relevance
Turn £10k Into £30k With AstraZeneca plc [Published Yahoo! Finance UK and Ireland - Sep 18 2014]
Lilly Joins AstraZeneca to Co-Develop BACE Inhi... [Published Genetic Engineering News - Sep 16 2014]
Lilly to Pay AstraZeneca $500 Million in Alzhei... [Published Bloomberg - Sep 16 2014]
City Spy: Cobra’s success a case of tabling a r... [Published London Evening Standard - Sep 11 2014]
US Government Closes Investigation Into Landmar... [Published Hammond Daily Star - Sep 10 2014]
Is Roche At Risk Of Losing Its Way? [Published Seeking Alpha - Sep 09 2014]
The Benefits Of Investing In AstraZeneca plc [Published Motley Fool UK - Sep 05 2014]
The Benefits Of Investing In AstraZeneca plc [Published Interactive Investor - Sep 05 2014]
US Government Closes Investigation Into Landmar... [Published Record Delta - Sep 05 2014]
AstraZeneca pressed Obama for help resisting Pf... [Published FiercePharma - Sep 04 2014]
AstraZeneca's Soriot brushes off chatter about ... [Published FiercePharma - Sep 03 2014]
Exclusive: 'Back To Normal' For AstraZeneca CEO... [Published IT Business Net - Sep 03 2014]
Vodafone enjoys late surge on bid talk [Published Telegraph - Sep 02 2014]
AstraZeneca Group 'back to normal' despite Pfiz... [Published Invezz - Sep 02 2014]
Exclusive: 'Back to normal' for AstraZeneca CEO... [Published Bayou Buzz - Sep 02 2014]
Exclusive: 'Back to normal' for AstraZeneca CEO... [Published Today Online - Sep 02 2014]
EXCLUSIVE-"Back to normal" for AstraZeneca CEO,... [Published CNBC - Sep 02 2014]
The Best Reason To Buy AstraZeneca plc [Published Interactive Investor - Aug 29 2014]
Round two? Market rumors on a new Pfizer bid fo... [Published FierceBiotech - Aug 29 2014]
US Department of Justice Closes Investigation i... [Published 4 Traders - Aug 28 2014]
Will Pfizer Take One Last Swing at AstraZeneca? [Published InvestorPlace.com - Aug 27 2014]
Heart disease to cost UK £18.4bn by 2020 [Published City A.M. - Aug 27 2014]
Western drugmakers try to shop their way out of... [Published Nikkei Asian Review - Aug 27 2014]
Window opens for Pfizer move on AstraZeneca [Da... [Published BusinessWeek - Aug 26 2014]
A New Pfizer Inc. Bid For AstraZeneca plc? [Published Yahoo! UK and Ireland - Aug 26 2014]
Window opens for Pfizer move on AstraZeneca [Published Mail Online UK - Aug 25 2014]
Round two: Window opens for Pfizer move on Astr... [Published This Is Money - Aug 25 2014]
Eli Lilly insulin receives tentative US approval [Published The Gulf Today - Aug 25 2014]
Balfour Beatty: The fine line between boldness ... [Published Telegraph - Aug 23 2014]
AstraZeneca shores up defences against Pfizer [Published Pharmafocus - Aug 22 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Pfizer Back For AstraZeneca? Year-end Move Seen... [Published Clusterstock - Aug 21 2014]
By Ben Hirschler LONDON (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt ...
US Department of Justice Closes Investigation i... [Published Business Wire Health News - Aug 19 2014]
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with BRILINTA® (ticagrelor) tablets. The government ...
AstraZeneca bolsters defences with strong sales [Published Proactiveinvestors United Kingdom website - Jul 31 2014]
AstraZeneca ( LON:AZN ) primed its defences against another assault from US pharma Pfizer by blasting past forecasts helped by a surge in sales of heart drug Brilinta. Sales rose by 4% to US$6.45bn (£3.8bn) in the three months to June  as  heart drug ...
"Not My Pay" says AZ's Soriot [Published The Big Red Biotech Blog - Jun 02 2014]
Fierce Pharma characterizes AZ's CEO Pascal Soriot as bristling to the idea that executive pay (including his own) should be tied to the sales forecast that he and board chairman Leif Johansson tossed out there as they tried to fend off Pfizer's takeover ...
Pfizer Decides AstraZeneca Isn’t Worth the Trou... [Published Wall St. Cheat Sheet - May 27 2014]
Source: Thinkstock After months of the chase, it seems Pfizer Inc.  ( NYSE:PFE ) has finally given up on its pursuit of British-Swedish drugmaker AstraZeneca Group Plc  ( NYSE:AZN ). The company announced in a statement on Monday that it would ...
1 2 3 4

Press Releases

sort by: Date | Relevance
US DOJ Closes Investigation into Plato [Published GlobeNewswire: Acquisitions News - Aug 19 2014]
AstraZeneca agrees strategic transaction with A... [Published AstraZeneca - Jul 30 2014]
Director/PDMR Shareholding [Published GlobeNewswire: Acquisitions News - Jul 01 2014]
ASTRAZENECA UPDATES ON THE RAPID PROGRESS OF ON... [Published GlobeNewswire: Advertising News - Jun 03 2014]
ASTRAZENECA BOARD REJECTS PFIZER’S FINAL PROPOSAL [Published AstraZeneca - May 19 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.